首页> 外文期刊>German Medical Science >Real world data in health technology assessments in kidney transplants in Germany: use of routinely collected data to address epidemiologic questions in kidney transplants in the AMNOG process in Germany
【24h】

Real world data in health technology assessments in kidney transplants in Germany: use of routinely collected data to address epidemiologic questions in kidney transplants in the AMNOG process in Germany

机译:德国肾脏移植健康技术评估中的真实世界数据:使用常规收集的数据来解决德国AMNOG流程中肾脏移植中的流行病学问题

获取原文
           

摘要

Introduction: It is discussed whether real world data can be used in health technology assessment. Following it is of interest whether routinely collected data for quality assurance (QA) in the hospital sector is feasible to address epidemiologic questions in kidney transplantation in the AMNOG process in Germany. Objectives: To investigate the proportion of kidney transplants classified as from so-called standard criteria donors (SCD) and from expanded criteria donors (ECD) in Germany and to study the age distribution. Methods: After granted use by the Federal Joint Committee (G-BA), the data analysis was carried out by the AQUA institute, and a SPSS code was developed. Special challenge was the complex definition of SCD/ECD criteria that, in addition to donor age, takes into account combinations of donor diagnoses, creatinine, and cold ischemia time. Results: Age analyses could be performed in all patients. Median age of the adult transplant recipients in Germany was 54 years in 2012 as well as in 2013, range 18–85 and 18–82 years and a mean (SD) of 53 (14) and 52 (14) years, respectively. 63.5% (2012) and 62.5% (2013) of recipients were male. Classification in SCD/ECD transplants could be performed for 2,083 of 2,461 patients (85%; 2012) and for 1,795 of 2,079 patients (86%; 2013). Of all classifiable transplants 61.4% (2012) and 66.5% (2013) were SCD transplants. Total project time from the request to results was <6 months. Conclusions: The use of data routinely collected for QA in the hospital sector is feasible to address epidemiologic questions in kidney transplantation in the AMNOG process in Germany, which is basically following the systematic of an HTA process. All patients with kidney transplants are represented thus avoiding sampling error. Limitations include the availability of all necessary data in the QA data set. Within <6 months’ time with reasonable resources it was possible to meet timelines. The analyses were accepted by the authorities.
机译:简介:讨论了是否可以将现实世界的数据用于卫生技术评估。值得关注的是,在德国的AMNOG流程中,常规收集医院质量保证(QA)数据是否可以解决肾脏移植中的流行病学问题。目的:调查在德国分类为所谓的标准标准供体(SCD)和扩展标准供体(ECD)的肾脏移植的比例,并研究年龄分布。方法:经联邦联合委员会(G-BA)批准使用后,由AQUA研究所进行数据分析,并开发了SPSS代码。特殊的挑战是SCD / ECD标准的复杂定义,除了供体年龄外,还考虑了供体诊断,肌酐和寒冷缺血时间的组合。结果:可以对所有患者进行年龄分析。 2012年和2013年,德国成年移植受者的中位年龄为54岁,分别为18-85岁和18-82岁,平均(SD)分别为53(14)和52(14)岁。 63.5%(2012)和62.5%(2013)的接受者为男性。 SCD / ECD移植中的分类可对2,461名患者中的2,083名(85%; 2012)和2,079名患者中的1,795名(86%; 2013)进行分类。在所有可分类移植中,有61.4%(2012)和66.5%(2013)是SCD移植。从请求到结果的项目总时间少于6个月。结论:在医院中,使用常规的QA数据来解决德国AMNOG流程中肾脏移植中的流行病学问题是可行的,这基本上是按照HTA流程进行的。代表了所有有肾脏移植的患者,从而避免了抽样误差。局限性包括质量检查数据集中所有必要数据的可用性。在不到6个月的时间内,只要有合理的资源,就可以达到时间表。分析被当局接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号